These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study. Legnani C; Palareti G; Cosmi B; Cini M; Tosetto A; Tripodi A; Haematologica; 2008 Jun; 93(6):900-7. PubMed ID: 18443269 [TBL] [Abstract][Full Text] [Related]
4. A review of the value of D-dimer testing for prediction of recurrent venous thromboembolism with increasing age. Lippi G; Favaloro EJ; Cervellin G Semin Thromb Hemost; 2014 Sep; 40(6):634-9. PubMed ID: 25099192 [TBL] [Abstract][Full Text] [Related]
5. D-dimer assays in diagnosis and management of thrombotic and bleeding disorders. Bates SM Semin Thromb Hemost; 2012 Oct; 38(7):673-82. PubMed ID: 23041982 [TBL] [Abstract][Full Text] [Related]
6. Multicenter evaluation of a new quantitative highly sensitive D-dimer assay, the Hemosil D-dimer HS 500, in patients with clinically suspected venous thromboembolism. Legnani C; Cini M; Scarvelis D; Toulon P; Wu JR; Palareti G Thromb Res; 2010 May; 125(5):398-401. PubMed ID: 19683797 [TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of cross linked fibrin degradation products in thrombotic disorders]. Koyama T; Oura Y; Higuchi M; Kakishita E; Nagai K Rinsho Ketsueki; 1989 May; 30(5):659-62. PubMed ID: 2677436 [TBL] [Abstract][Full Text] [Related]
8. The role of D-dimer testing in patients with suspected venous thromboembolism. Prisco D; Grifoni E Semin Thromb Hemost; 2009 Feb; 35(1):50-9. PubMed ID: 19308893 [TBL] [Abstract][Full Text] [Related]
9. D-dimer use for deep venous thrombosis exclusion in elderly patients: a comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer units. Cini M; Legnani C; Frascaro M; Sartori M; Cosmi B; Palareti G Int J Lab Hematol; 2014 Oct; 36(5):541-7. PubMed ID: 24428869 [TBL] [Abstract][Full Text] [Related]
10. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism. Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709 [TBL] [Abstract][Full Text] [Related]
11. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. Goldenberg NA; Knapp-Clevenger R; Manco-Johnson MJ; N Engl J Med; 2004 Sep; 351(11):1081-8. PubMed ID: 15356305 [TBL] [Abstract][Full Text] [Related]
12. Comparison of D-dimer point of care test (POCT) against current laboratory test in patients with suspected venous thromboembolism (VTE) presenting to the emergency department (ED). Sen B; Kesteven P; Avery P J Clin Pathol; 2014 May; 67(5):437-40. PubMed ID: 24307452 [TBL] [Abstract][Full Text] [Related]
13. Different accuracies of rapid enzyme-linked immunosorbent, turbidimetric, and agglutination D-dimer assays for thrombosis exclusion: impact on diagnostic work-ups of outpatients with suspected deep vein thrombosis and pulmonary embolism. Michiels JJ; Gadisseur A; van der Planken M; Schroyens W; De Maeseneer M; Hermsen JT; Trienekens PH; Hoogsteden H; Pattynama PM Semin Thromb Hemost; 2006 Oct; 32(7):678-93. PubMed ID: 17024595 [TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of eight different D-dimer tests for the exclusion of deep venous thrombosis in primary care patients. Oude Elferink RF; Loot AE; Van De Klashorst CG; Hulsebos-Huygen M; Piersma-Wichers M; Oudega R Scand J Clin Lab Invest; 2015 May; 75(3):230-8. PubMed ID: 25608596 [TBL] [Abstract][Full Text] [Related]
15. Adapting the D-dimer cutoff for thrombosis detection in elderly outpatients. Andro M; Righini M; Le Gal G Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):751-9. PubMed ID: 23750684 [TBL] [Abstract][Full Text] [Related]
17. Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation products. Madoiwa S; Kitajima I; Ohmori T; Sakata Y; Mimuro J Thromb Res; 2013 Oct; 132(4):457-64. PubMed ID: 24011388 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of the Triage D-dimer test for exclusion of venous thromboembolism in outpatients. Ghys T; Achtergael W; Verschraegen I; Leus B; Jochmans K Thromb Res; 2008; 121(6):735-41. PubMed ID: 17888501 [TBL] [Abstract][Full Text] [Related]
19. The harmonization of quantitative test results of different D-dimer methods. Meijer P; Kluft C Semin Vasc Med; 2005 Nov; 5(4):321-7. PubMed ID: 16302153 [TBL] [Abstract][Full Text] [Related]
20. D-dimer: An Overview of Hemostasis and Fibrinolysis, Assays, and Clinical Applications. Olson JD Adv Clin Chem; 2015; 69():1-46. PubMed ID: 25934358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]